KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alto Ingredients (ALTO) EBT (2016 - 2025)

Alto Ingredients' EBT history spans 15 years, with the latest figure at $21.2 million for Q4 2025.

  • For Q4 2025, EBT rose 151.0% year-over-year to $21.2 million; the TTM value through Dec 2025 reached $12.7 million, up 121.62%, while the annual FY2025 figure was $12.7 million, 121.62% up from the prior year.
  • EBT reached $21.2 million in Q4 2025 per ALTO's latest filing, up from $14.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $37.6 million in Q4 2021 to a low of -$41.5 million in Q4 2024.
  • Average EBT over 5 years is -$3.3 million, with a median of -$3.1 million recorded in 2021.
  • Peak YoY movement for EBT: tumbled 795.21% in 2022, then soared 682.06% in 2025.
  • A 5-year view of EBT shows it stood at $37.6 million in 2021, then tumbled by 182.8% to -$31.1 million in 2022, then skyrocketed by 39.49% to -$18.8 million in 2023, then plummeted by 120.39% to -$41.5 million in 2024, then skyrocketed by 151.0% to $21.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALTO's EBT are $21.2 million (Q4 2025), $14.2 million (Q3 2025), and -$11.0 million (Q2 2025).